Broker-Dealers on SEC Form D for MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED

Search by Recipient Name or Primary Issuer:

Displaying 371-380 out of 1,218 results

Recipient	CRD	Primary Issuer	CIK	Filing Date	Form Type	Total Offering Amount	Total Amount Sold
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED	7691	AQR Tax Advantaged Global Equity Market Neutral Fund, L.P.	1616851	11/10/2022	D/A	Indefinite	$389,456,414
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED	7691	AQR Tax Advantaged Global Equity Market Neutral Fund, L.P.	1616851	02/09/2023	D/A	Indefinite	$389,456,414
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED	7691	Blackstone Strategic Partners Secondaries VII Trust	1675278	05/31/2016	D	Indefinite	$388,727,000
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED	7691	AQR Tax Advantaged Global Equity Market Neutral Fund, L.P.	1616851	05/12/2022	D/A	Indefinite	$388,556,414
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED	7691	Paulson Advantage Access LLC	1340702	03/12/2012	D/A	Indefinite	$387,418,242
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED	7691	AQR Tax Advantaged Global Equity Market Neutral Fund, L.P.	1616851	02/10/2022	D/A	Indefinite	$385,556,414
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED	7691	AQR Tax Advantaged Global Equity Market Neutral Fund, L.P.	1616851	11/12/2021	D/A	Indefinite	$384,606,414
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED	7691	Blackstone Life Sciences V Access Fund, L.P.	1817675	09/18/2020	D/A	$383,868,991	$383,868,991
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED	7691	AQR Tax Advantaged Global Equity Market Neutral Fund, L.P.	1616851	09/09/2021	D/A	Indefinite	$383,706,414
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED	7691	AQR Tax Advantaged Global Equity Market Neutral Fund, L.P.	1616851	08/12/2021	D/A	Indefinite	$383,206,414